What to do: Stop using the affected product. If your child shows sign/symptoms of acetaminophen overdose (as specified below), call your local poison control centre or emergency health care services immediately. Consult a health care professional if you have questions or concerns about your child's health.
Teva Canada Ltd. is recalling one lot of Pediatrix Acetaminophen Oral Solution after routine product testing found a higher than acceptable amount of acetaminophen in the affected lot (approximately 185mg/5mL rather than the approved and labelled 160mg/5mL). This could lead to children receiving too much acetaminophen. Children may be especially at risk of the effects of acetaminophen overdose given their small size and developing bodies.
Signs of acetaminophen overdose include nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach. Abdominal pain may be the first sign of liver damage and may not be apparent for 24 to 48 hours. Liver damage may result in liver failure or, in the most severe cases, death.
The product is available without a prescription and is used to relieve mild to moderate pain and fever in children from 2 to 11 years of age.
Health Canada is monitoring the company's recall and its implementation of any necessary corrective and preventative actions. It will inform the public if any new health risks are identified.
Given the limited scope of the recall, it will not have any impact on the general availability of children's acetaminophen products.
What you should do
Verify the lot number on your medication. The lot number on a medication bottle is commonly found next to the expiration date.
Stop using the affected product. If your child shows signs/symptoms of acetaminophen overdose, such as nausea, vomiting, lethargy, sweating, loss of appetite and pain in the upper part of the abdomen or stomach, call your local poison control centre or emergency health care services immediately. Consult a health care professional if you have questions or concerns about your child's health.
Return the product to your local pharmacy for proper disposal. Contact Teva Canada Customer Care by calling 1-800-268-4129, or emailing [email protected], if you have questions about the recall.
The Foundation Fighting Blindness, the driving force in the global development of treatments and cures for blinding diseases, will host its VISIONS 2024 conference at the Chicago Marriott Downtown Magnificent Mile on June 21?22, 2024. This biennial...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a new groundbreaking algorithm, SignalHF1, used...
The American Trucking Associations is calling attention to the negative consequences for highway safety and safety-sensitive industries that could result from the U.S. Drug Enforcement Administration's proposal to reschedule marijuana from a Schedule...
- AbbVie will present 15 abstracts, including three oral presentations, in Crohn's disease and ulcerative colitis reinforcing AbbVie's commitment to advancing the standards of care in inflammatory bowel diseases (IBD)- Data to be presented from...
We are advised by OsteoStrong that journalists and other readers should disregard the news release, OsteoStrong Celebrates Success and Innovation at 11th Annual Global Franchise Owner Convention, issued May 9, 2024 over PR Newswire.
SOURCE...
Precision BioSciences, Inc. , an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion, excision, and elimination, today...